SCHEMBL6327447

SCHEMBL6327447

CC(C)(C)N(OC(=O)c1ccccc1)c1ccc(C(=O)Nc2nccs2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.62
NPC1 O15118 5/20 0.62
SCD O00767 1/20 0.60
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
SMN1; SMN2 Q16637 5/20 0.57
HSD17B10 Q99714 2/20 0.57
LMNA P02545 2/20 0.57
ALDH1A1 P00352 2/20 0.57
GBA1 P04062 1/20 0.57
HPGD P15428 1/20 0.57
TSHR P16473 1/20 0.57
MAPK1 P28482 1/20 0.57
MAPK10 P53779 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
GLA P06280 2/20 0.54
POLB P06746 2/20 0.53
ADORA2A P29274 2/20 0.53
KCNK3 O14649 1/20 0.53
KCNK9 Q9NPC2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6328478 0.87 RAB9A (0.61) RAB9ANPC1SCDMEN1KMT2A
SCHEMBL6330130 0.81 RAB9A (0.57) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL6330529 0.81 RAB9A (0.55) RAB9ANPC1SCDMEN1KMT2A
SCHEMBL995829 0.79 NPC1 (1.00) RAB9ANPC1SCDMEN1KMT2A
SCHEMBL6328266 0.78 NPC1 (0.64) RAB9ANPC1SCDMEN1KMT2A
SCHEMBL6327764 0.78 NPC1 (0.57) RAB9ANPC1SCDMEN1KMT2A
Hydrochloric Acid SCHEMBL27594584 0.77 NPC1 (0.97) RAB9ANPC1SCDMEN1KMT2A
SCHEMBL4295195 0.76 RAB9A (0.76) RAB9ANPC1SCDMEN1KMT2A
SCHEMBL16562033 0.76 SCD (1.00) RAB9ANPC1SCDMEN1KMT2A
SCHEMBL4285954 0.75 NPC1 (0.85) RAB9ANPC1SCDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949654-B2 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SAM-SUNG ELECTRONICS CO., LTD. (KR) 2005-09-27 US claimed
US-6949654-B2 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SAM-SUNG ELECTRONICS CO., LTD. (KR) 2005-09-27 US disclosed
US-20030225087-A1 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SAM-SUNG ELECTRONICS CO., LTD. (KR) 2003-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225087-A1 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses SOD1, LPO, BAD RAB9A 539/4885NPC1 322/4885SCD 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.